Search research articles
Contact Us
Filters
Showing results (591-600 of 736) with videos related to
Page
of 74
Sort By:
Reviews in Endocrine & Metabolic Disorders
|
May 6, 2026
Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)
Roberto Vettor, Maria Letizia Petroni, Idit Dotan, et al.
Free Radical Biology & Medicine
|
October 27, 2018
Resveratrol decreases the expression of genes involved in inflammation through transcriptional regulation
Daniele Maria Lopes Pinheiro, Ana Helena Sales de Oliveira, Leonam Gomes Coutinho, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 7, 2019
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity
Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, et al.
Journal of Hepatology
|
October 27, 2023
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease
Federico Salomone, Rosaria Maria Pipitone, Miriam Longo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 22, 2020
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD
Stefania Grimaudo, Stefano Bartesaghi, Raffaela Rametta, et al.
Scientific Reports
|
March 8, 2019
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Serena Pelusi, Guido Baselli, Alessandro Pietrelli, et al.
Journal of Viral Hepatitis
|
April 25, 2021
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort
Vincenza Calvaruso, Salvatore Petta, Irene Cacciola, et al.
The Lancet. Gastroenterology & Hepatology
|
May 13, 2017
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
Salvatore Petta, Marco Marzioni, Pierluigi Russo, et al.
Gastroenterology
|
July 24, 2012
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis
Erica Villa, Calogero Cammà, Marco Marietta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 6, 2023
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease
Chiara Rosso, Gian Paolo Caviglia, Giovanni Birolo, et al.
Page
of 74
Search research articles
Search
Showing results (591-600 of 736) with videos related to
Sort By:
Page
of 74
Reviews in Endocrine & Metabolic Disorders
|
May 6, 2026
Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH)
Roberto Vettor, Maria Letizia Petroni, Idit Dotan, et al.
Free Radical Biology & Medicine
|
October 27, 2018
Resveratrol decreases the expression of genes involved in inflammation through transcriptional regulation
Daniele Maria Lopes Pinheiro, Ana Helena Sales de Oliveira, Leonam Gomes Coutinho, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 7, 2019
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity
Stefania Di Mauro, Alessandra Scamporrino, Salvatore Petta, et al.
Journal of Hepatology
|
October 27, 2023
SIRT5 rs12216101 T>G variant is associated with liver damage and mitochondrial dysfunction in patients with non-alcoholic fatty liver disease
Federico Salomone, Rosaria Maria Pipitone, Miriam Longo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 22, 2020
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with NAFLD
Stefania Grimaudo, Stefano Bartesaghi, Raffaela Rametta, et al.
Scientific Reports
|
March 8, 2019
Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Serena Pelusi, Guido Baselli, Alessandro Pietrelli, et al.
Journal of Viral Hepatitis
|
April 25, 2021
Liver and cardiovascular mortality after hepatitis C virus eradication by DAA: Data from RESIST-HCV cohort
Vincenza Calvaruso, Salvatore Petta, Irene Cacciola, et al.
The Lancet. Gastroenterology & Hepatology
|
May 13, 2017
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study
Salvatore Petta, Marco Marzioni, Pierluigi Russo, et al.
Gastroenterology
|
July 24, 2012
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis
Erica Villa, Calogero Cammà, Marco Marietta, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 6, 2023
Impact of PNPLA3 rs738409 Polymorphism on the Development of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease
Chiara Rosso, Gian Paolo Caviglia, Giovanni Birolo, et al.
Page
of 74